S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
OTCMKTS:BNKL

Bionik Laboratories (BNKL) Stock Forecast, Price & News

$0.60
-0.39 (-39.39%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.60
▼
$1.00
50-Day Range
$0.26
▼
$0.62
52-Week Range
$0.25
▼
$2.90
Volume
1,511 shs
Average Volume
126 shs
Market Capitalization
$4.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest

BNKL stock logo

About Bionik Laboratories (OTCMKTS:BNKL) Stock

Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. Its products include InMotion ARM, InMotion HAND, and InMotion WRIST. The company was founded by Michal Prywata and Thiago Caires on January 8, 2010 and is headquartered in Watertown, MA.

Receive BNKL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionik Laboratories and its competitors with MarketBeat's FREE daily newsletter.

BNKL Stock News Headlines

May 23, 2023 | finance.yahoo.com
Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
May 4, 2023 | finance.yahoo.com
Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong
June 10, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
May 2, 2023 | americanbankingnews.com
Head to Head Survey: Bionik Laboratories (OTCMKTS:BNKL) vs. Bone Biologics (OTC:BBLG)
March 23, 2023 | finance.yahoo.com
Bionik Laboratories’ InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)
February 10, 2023 | investing.com
Zenotech Laboratories Ltd (ZENL)
February 10, 2023 | investing.com
Caplin Point Laboratories Ltd (CAPL)
February 8, 2023 | finance.yahoo.com
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
June 10, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
January 23, 2023 | nbcnews.com
After baby formula problems, Abbott Laboratories under DOJ investigation
January 23, 2023 | cnbc.com
Abbott Laboratories reportedly faces U.S. criminal probe over baby formula shortage
January 18, 2023 | marketwatch.com
Bionic Limbs Market Share From 2023 To 2028 And Unlimited Opportunities for New Companies and Latest Developments
November 9, 2022 | finance.yahoo.com
Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results
November 7, 2022 | finance.yahoo.com
Bionik Laboratories to Present at the Q4 Virtual Investor Summit
October 13, 2022 | seekingalpha.com
Bionik laboratories appoints new CEO and CFO
October 13, 2022 | finance.yahoo.com
Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer
September 8, 2022 | finance.yahoo.com
Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout
September 1, 2022 | finance.yahoo.com
BIONIK Laboratories to Present at National Investment Banking Association Conference
August 17, 2022 | investing.com
Bionik Laboratories Corp (BNKL)
August 10, 2022 | finance.yahoo.com
BIONIK Laboratories Reports First Quarter Financial Results
August 9, 2022 | tmcnet.com
BIONIK Laboratories Corp. to Present at Investor Summit Group's Q3 Virtual Conference
August 9, 2022 | finance.yahoo.com
BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference
June 23, 2022 | finance.yahoo.com
BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center
June 9, 2022 | finance.yahoo.com
BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results
May 27, 2022 | yahoo.com
The 5 Consequences of Not Spending Enough Time Outdoors
May 25, 2022 | finance.yahoo.com
BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors
March 30, 2022 | finance.yahoo.com
BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo
See More Headlines

BNKL Price History

BNKL Company Calendar

Today
6/09/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BNKL
CUSIP
N/A
CIK
1508381
Web
www.bioniklabs.com
Phone
(617) 926-4800
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,410,000.00
Net Margins
-354.11%
Pretax Margin
-354.11%
Return on Equity
-459.32%
Return on Assets
-128.34%

Debt

Debt-to-Equity Ratio
1.47
Current Ratio
1.47
Quick Ratio
0.92

Sales & Book Value

Annual Sales
$1.27 million
Price / Sales
3.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.43 per share
Price / Book
1.40

Miscellaneous

Outstanding Shares
6,770,000
Free Float
4,419,000
Market Cap
$4.06 million
Optionable
Not Optionable
Beta
-1.23

Key Executives

  • Richard Russo
    President, Chief Executive Officer & Director
  • Dan Gonsalves
    Chief Financial Officer & Executive Vice President

Key Competitors

View All Competitors













BNKL Stock - Frequently Asked Questions

How have BNKL shares performed in 2023?

Bionik Laboratories' stock was trading at $0.6225 on January 1st, 2023. Since then, BNKL shares have decreased by 3.6% and is now trading at $0.60.
View the best growth stocks for 2023 here.

When is Bionik Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our BNKL earnings forecast.

What other stocks do shareholders of Bionik Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bionik Laboratories investors own include Co-Diagnostics (CODX), iBio (IBIO), Revvity (PKI), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX) and Digital Ally (DGLY).

What is Bionik Laboratories' stock symbol?

Bionik Laboratories trades on the OTCMKTS under the ticker symbol "BNKL."

How do I buy shares of Bionik Laboratories?

Shares of BNKL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bionik Laboratories' stock price today?

One share of BNKL stock can currently be purchased for approximately $0.60.

How much money does Bionik Laboratories make?

Bionik Laboratories (OTCMKTS:BNKL) has a market capitalization of $4.06 million and generates $1.27 million in revenue each year. The company earns $-10,410,000.00 in net income (profit) each year or ($0.81) on an earnings per share basis.

How can I contact Bionik Laboratories?

Bionik Laboratories' mailing address is 483 Bay Street N105, Toronto A6, M5G2C9. The official website for the company is www.bioniklabs.com. The company can be reached via phone at (617) 926-4800 or via email at lm@bioniklabs.com.

This page (OTCMKTS:BNKL) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -